Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Infect Dis. 2014 Apr;27(2):165-73. doi: 10.1097/QCO.0000000000000045.

Antibiotic therapy of pneumonia in the obese patient: dosing and delivery.

Author information

  • 1aIntensive Care Department, King Abdulaziz Medical City - Riyadh bCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences cMedical Surgical Intensive Care Unit, King Abdulaziz Medical City - Riyadh dCollege of Pharmacy, King Saud bin Abdulaziz University for Health Sciences.

Abstract

PURPOSE OF REVIEW:

Obesity has been shown to be associated with antibiotic underdosing and treatment failure. This article reviews the recent literature on antibiotic dosing in obese patients with pneumonia.

RECENT FINDINGS:

Obesity is associated with several alterations in antibiotic pharmacokinetics and pharmacodynamics, including increases in the antibiotic volume of distribution and clearance. These alterations necessitate changes in the dosing of certain antibiotics. However, data on antibiotic dosing for pneumonia in obese patients are limited and come mainly from observational studies. Additionally, dosing recommendations are often extrapolated from healthy obese volunteers and from the studies of antibiotics given for other indications.

SUMMARY:

Recognizing obesity-related pharmacokinetic and pharmacodynamic alterations is important in treating obese patients with pneumonia. Studies that evaluate such alterations and assess the impact of antibiotic dosing and delivery on the clinical outcomes of this patient population are needed.

PMID:
24504134
[PubMed - in process]
PMCID:
PMC3940399
Free PMC Article

Images from this publication.See all images (4)Free text

Box 1
FIGURE 1
FIGURE 2
FIGURE 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Write to the Help Desk